NeoGenomics, Inc. (NEO)

Price$10.90

Value ScoreD

Growth ScoreB

Momentum ScoreB

Favorite Metrics

Price vs S&P 500 (26W)-17.84%

Price vs S&P 500 (4W)21.66%

VGM Score55.68

Market Capitalization$1.42B

All Metrics

P/CF (Annual)271.38x

Book Value / Share (Quarterly)$6.39

P/TBV (Annual)2.77x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)12.58%

Cash Flow / Share (Quarterly)$-0.04

Price vs S&P 500 (YTD)-15.47%

Gross Margin (TTM)43.15%

Net Profit Margin (TTM)-13.30%

EPS (TTM)$-0.77

10-Day Avg Trading Volume1.32M

EPS Excl Extra (TTM)$-0.77

Revenue Growth (5Y)10.35%

EPS (Annual)$-0.84

ROI (Annual)-9.17%

Gross Margin (Annual)43.21%

Net Profit Margin (5Y Avg)-14.33%

Cash / Share (Quarterly)$1.13

Revenue Growth QoQ (YoY)11.09%

ROA (Last FY)-7.94%

Revenue Growth TTM (YoY)10.95%

EBITD / Share (TTM)$-0.73

ROE (5Y Avg)-9.24%

Operating Margin (TTM)-14.25%

Cash Flow / Share (Annual)$-0.17

P/B Ratio1.71x

P/B Ratio (Quarterly)1.17x

Net Income / Employee (Annual)$-43,200

EV / Revenue (TTM)2.17x

Net Interest Coverage (TTM)-105.20x

ROA (TTM)-7.25%

EV / EBITDA (TTM)115.39x

EPS Incl Extra (Annual)$-0.84

Current Ratio (Annual)4.26x

Quick Ratio (Quarterly)3.79x

3-Month Avg Trading Volume1.89M

52-Week Price Return52.88%

Revenue / Employee (TTM)$298,400

Tangible BV / Share (Quarterly)$4.24

P/S Ratio (Annual)1.95x

Asset Turnover (Annual)0.53x

52-Week High$13.74

Operating Margin (5Y Avg)-20.71%

EPS Excl Extra (Annual)$-0.84

CapEx CAGR (5Y)-1.48%

Tangible BV CAGR (5Y)-0.84%

26-Week Price Return-9.92%

Quick Ratio (Annual)3.70x

13-Week Price Return19.39%

Total Debt / Equity (Annual)0.41x

Current Ratio (Quarterly)4.42x

Enterprise Value$1.62B

Revenue / Share Growth (5Y)7.39%

Asset Turnover (TTM)0.55x

Book Value / Share Growth (5Y)0.93%

Revenue / Employee (Annual)$290,900

Inventory Turnover (Annual)14.93x

Pretax Margin (Annual)-15.16%

Cash / Share (Annual)$1.24

3-Month Return Std Dev55.30%

Gross Margin (5Y Avg)40.79%

Net Income / Employee (TTM)$-39,700

ROE (Last FY)-12.91%

Net Interest Coverage (Annual)-43.50x

EPS Basic Excl Extra (Annual)$-0.84

P/FCF (TTM)97.58x

Receivables Turnover (TTM)4.68x

Total Debt / Equity (Quarterly)0.41x

EPS Incl Extra (TTM)$-0.77

Receivables Turnover (Annual)4.69x

ROI (TTM)-8.40%

P/S Ratio (TTM)1.90x

Pretax Margin (5Y Avg)-15.63%

Revenue / Share (Annual)$5.68

Tangible BV / Share (Annual)$4.26

Forward P/E43.02x

Price vs S&P 500 (52W)28.51%

Year-to-Date Return-7.31%

5-Day Price Return4.41%

EPS Normalized (Annual)$-0.84

ROA (5Y Avg)-5.34%

Net Profit Margin (Annual)-14.85%

Month-to-Date Return3.61%

Cash Flow / Share (TTM)$-0.19

EBITD / Share (Annual)$-0.63

Operating Margin (Annual)-15.93%

LT Debt / Equity (Annual)0.41x

P/CF (TTM)63.31x

ROI (5Y Avg)-6.10%

LT Debt / Equity (Quarterly)0.41x

EPS Basic Excl Extra (TTM)$-0.77

P/TBV (Quarterly)1.76x

P/B Ratio (Annual)1.82x

Inventory Turnover (TTM)14.23x

Pretax Margin (TTM)-13.70%

Book Value / Share (Annual)$6.49

Price vs S&P 500 (13W)11.13%

Beta1.84x

P/FCF (Annual)424.94x

Revenue / Share (TTM)$5.78

ROE (TTM)-11.82%

52-Week Low$4.72

vGradeD

gGradeB

mGradeB

vgmGradeC

Show chart for

Earnings Surprise History

Q1 260.01est. 0.01

Analyst Recommendations

Feb 2026

Mar 2026

Apr 2026

May 2026

3.53

3.61

3.82

Industry Peers — Testing Laboratories(3)

Symbol	Value Score	Growth Score	Momentum Score	Price
NEONeoGenomics, Inc.	D	B	B	$10.90
ULSUL Solutions Inc.	F	C	B	$96.81
BNBXBNB Plus Corp. Common Stock	B	D	F	$0.54
AIDX20/20 Biolabs, Inc. Common Stock	—	—	D	$0.80

About

NeoGenomics Inc provides comprehensive oncology diagnostic testing and services through laboratories in the United States and United Kingdom. The company's offerings include clinical cancer testing, molecular and next-generation sequencing testing, professional interpretation, consultative services, clinical trial support, validation services, and oncology data solutions.